⌘K

Login Start Free

Home/Filings/4/0001822629-25-000008

4//SEC Filing

Lalwani Nikhil 4

Accession 0001822629-25-000008

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:47 PM ET

Size

5.1 KB

Accession

0001822629-25-000008

Insider Transaction Report

Form 4

Period: 2025-03-23

ANI PHARMACEUTICALS INCANIP

DirectorPRESIDENT & CEO

Transactions

Tax Payment
Common Stock
2025-03-23$64.26/sh−17,455$1,121,658→ 468,179 total

Footnotes (1)

[F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported.

Documents

1 file

4
wk-form4_1742935660.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001822629

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 4:47 PM ET
Size: 5.1 KB

View on SEC.gov